Ridgeback Capital logo

Ridgeback Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series A

Hinge Bio logo
Hinge Bio

Biotechnology

Ridgeback Capital logo
Point72 logo
Lightswitch Capital logo
InVivium Capital logo

Hinge Bio is a biotechnology company developing multivalent, multispecific antibody-based therapeutics for autoimmune, inflammatory, infectious diseases, and cancer.

Series A
$30M
01/15/2025
Article